Risk Factors for Infective Endocarditis in Contegra Grafts Used as Right Ventricle-Pulmonary Artery Conduits: A...

Area of Science:

• Cardiovascular Surgery
• Infectious Diseases
• Biomaterials Science

Background:

• Bovine jugular vein grafts like Contegra are crucial for right ventricular outflow tract reconstruction.
• Recent data suggest a concerning incidence of infective endocarditis (IE) with Contegra use.
• Understanding risk factors for Contegra-associated IE is vital for patient safety.

Purpose of the Study:

• To evaluate the clinical features of infective endocarditis (IE) in patients with Contegra grafts.
• To identify risk factors associated with the development of IE after Contegra implantation.
• To assess the incidence and outcomes of IE in this patient population.

Main Methods:

• Retrospective review of 206 patients undergoing Contegra implantation for RVOT reconstruction (2016-2023).
• Analysis of patient demographics, graft characteristics, and clinical outcomes, including IE development.
• Cox regression analysis to determine risk factors for IE; echocardiographic parameters were assessed.

Main Results:

• 13 patients (6.3%) developed IE at a median of 27.1 months post-implantation.
• Gram-positive cocci were the most common pathogens (84.6%).
• Higher postoperative conduit peak flow velocity (≥1.45 m/s) was the sole significant risk factor for IE (HR 4.01).

Conclusions:

• Infective endocarditis (IE) is a significant complication following Contegra implantation, occurring in 6.3% of patients.
• Elevated conduit peak flow velocity on immediate postoperative echocardiography is a key predictor of increased IE risk.
• Early detection and management strategies may be warranted for patients with high-risk flow velocities.